Voluntary Faculty
Voluntary faculty are typically clinicians or others who are employed outside of the School but make significant contributions to department programs at the medical center or at affiliate institutions.
Voluntary rank detailsVladimir Coric, MD
Associate Clinical ProfessorDownloadHi-Res Photo
About
Copy Link
Appointments
Education & Training
- Fellowship in Forensic Psychiatry
- Yale University School of Medicine (2001)
- Chief Resident, Post-Traumatic Stress Disorder Firm
- National Center for PTSD, VA Connecticut Healthcare System (2000)
- Program-Wide Chief Resident
- Yale University School of Medicine (2000)
- Yale Psychiatry Residency Training Program
- Yale University School of Medicine (2000)
- MD
- Wake Forest University (1996)
Research
Copy Link
Research at a Glance
Yale Co-Authors
Frequent collaborators of Vladimir Coric's published research.
Publications Timeline
A big-picture view of Vladimir Coric's research output by year.
Angeli Landeros-Weisenberger, MD
Michael Bloch, MD, MS
Dan Oren, MD, BS
Christopher van Dyck, MD
Jesse M. Cedarbaum, MD, FAAN (Neurology), FANA
John Krystal, MD
61Publications
3,589Citations
Publications
2026
Incorporating Patient Perspectives into a Composite Score for Measuring Disease Progression in Spinocerebellar Ataxia (SCA)
Potashman M, Rogula B, Powell L, Korol E, Dickson S, Hendrix S, Heinrich M, Rudell K, Abetz-Webb L, Beiner M, Coric V, Rosenthal L, Perlman S, Schmahmann J, L’Italien G. Incorporating Patient Perspectives into a Composite Score for Measuring Disease Progression in Spinocerebellar Ataxia (SCA). Neurology And Therapy 2026, 15: 807-816. PMID: 41706362, PMCID: PMC12965947, DOI: 10.1007/s40120-026-00891-6.Peer-Reviewed Original ResearchAltmetricPatient outcomes in KCNQ2 developmental and epileptic encephalopathy
Maclaine G, Potashman M, Pawar D, Sharma S, Rudell K, Lerner J, Coric V, Berg A, Millichap J, L'Italien G. Patient outcomes in KCNQ2 developmental and epileptic encephalopathy. Developmental Medicine & Child Neurology 2026 PMID: 41527503, DOI: 10.1111/dmcn.70124.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsCitationsAltmetric
2025
Development of composite scales for assessing disease progression and treatment effects among patients with Parkinson's disease in a clinical trial setting
L'Italien G, Rogula B, Powell L, Potashman M, Dickson S, Kozauer N, O'Keefe P, Korol E, Crabtree M, Nagase F, Coric V, Dubow J, Rosenthal L, Hendrix S, Database C. Development of composite scales for assessing disease progression and treatment effects among patients with Parkinson's disease in a clinical trial setting. Parkinsonism & Related Disorders 2025, 141: 108077. PMID: 41106090, DOI: 10.1016/j.parkreldis.2025.108077.Peer-Reviewed Original ResearchCitationsUnderstanding lived experiences with KCNQ2 developmental and epileptic encephalopathy
Potashman M, Rudell K, Abetz-Webb L, Suminski N, Gold A, Doma R, Jarodia K, Buckley C, Ridley M, Lerner J, Mather J, Coric V, Numis A, Sands T, Millichap J, Berg A, L'Italien G. Understanding lived experiences with KCNQ2 developmental and epileptic encephalopathy. Epilepsy & Behavior 2025, 172: 110670. PMID: 40912075, DOI: 10.1016/j.yebeh.2025.110670.Peer-Reviewed Original ResearchCitationsAltmetricDevelopment and Validation of PARCOMS Composite Scales for Assessing Disease Progression and Treatment Effects in Parkinson’s Disease
L’Italien G, Rogula B, Powell L, Potashman M, Dickson S, Kozauer N, O’Keefe P, Korol E, Crabtree M, Nagase F, Coric V, Dubow J, Rosenthal L, Hendrix S. Development and Validation of PARCOMS Composite Scales for Assessing Disease Progression and Treatment Effects in Parkinson’s Disease. Neurology And Therapy 2025, 14: 1609-1625. PMID: 40518466, PMCID: PMC12255624, DOI: 10.1007/s40120-025-00771-5.Peer-Reviewed Original ResearchCitationsContent Validity of the Friedreich Ataxia Rating Scale in Patients with Spinocerebellar Ataxia
Potashman M, Rudell K, Suminski N, Doma R, Heinrich M, Abetz-Webb L, Beiner M, Coric V, Rosenthal L, Kuo S, Zesiewicz T, Fife T, van de Warrenburg B, Ristori G, Synofzik M, Subramony S, Perlman S, Schmahmann J, L’Italien G. Content Validity of the Friedreich Ataxia Rating Scale in Patients with Spinocerebellar Ataxia. Neurology And Therapy 2025, 14: 547-563. PMID: 39812736, PMCID: PMC11906946, DOI: 10.1007/s40120-024-00704-8.Peer-Reviewed Original ResearchCitationsAltmetricMeasurement Properties of the Friedreich Ataxia Rating Scale in Patients with Spinocerebellar Ataxia
Potashman M, Popoff E, Powell L, Beiner M, Mackenzie A, Coric V, Subramony S, Synofzik M, Schmahmann J, L’Italien G. Measurement Properties of the Friedreich Ataxia Rating Scale in Patients with Spinocerebellar Ataxia. Neurology And Therapy 2025, 14: 527-545. PMID: 39806095, PMCID: PMC11906947, DOI: 10.1007/s40120-024-00708-4.Peer-Reviewed Original ResearchCitationsContent Validity of the Spinocerebellar Ataxia Composite Score as a Measure of Disease Progression in Patients with Spinocerebellar Ataxia
Potashman M, Heinrich M, Rudell K, Abetz-Webb L, Suminski N, Doma R, Jarodia K, Jain M, Buckley C, Wolfe-Beiner M, Coric V, Perlman S, Rosenthal L, Schmahmann J, L’Italien G. Content Validity of the Spinocerebellar Ataxia Composite Score as a Measure of Disease Progression in Patients with Spinocerebellar Ataxia. The Cerebellum 2025, 24: 146. PMID: 40888983, PMCID: PMC12401751, DOI: 10.1007/s12311-025-01896-x.Peer-Reviewed Original ResearchCitationsAltmetric
2024
Determinants of health‐related quality of life of patients with focal epilepsy: A systematic literature review
Engelhart P, Marcin C, Lerner J, Dill D, L'Italien G, Coric V, Matsumoto J, Potashman M. Determinants of health‐related quality of life of patients with focal epilepsy: A systematic literature review. Epileptic Disorders 2024, 27: 9-30. PMID: 39545796, PMCID: PMC11829624, DOI: 10.1002/epd2.20292.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsCitationsAltmetricMeSH KeywordsThe impact of anti-inflammatory therapy on Parkinson's disease incidence: A retrospective cohort study
Potashman M, Haas J, Pandit A, Stafkey D, Coric V, Singer W, L'Italien G. The impact of anti-inflammatory therapy on Parkinson's disease incidence: A retrospective cohort study. Parkinsonism & Related Disorders 2024, 130: 107194. PMID: 39541724, DOI: 10.1016/j.parkreldis.2024.107194.Peer-Reviewed Original ResearchCitationsAltmetric
News
Copy Link
News
Get In Touch
Copy Link